Search
for
Sort by
Research 391–420 of 1000+
- Chitosan stimulates root hair callose deposition and inhibits root hair growth
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- Pharmacological Activation of Thermo–Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath
- Role of -catenin in Epidermal Stem Cell Expansion, Lineage Selection, and Cancer
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non‐depilated mouse model
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Cutaneous drug reactions
- Pharmacological Treatment of Alopecia
- Hypertensive crisis associated with St. John’s Wort
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
- Androgenetic alopecia; drug safety and therapeutic strategies
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Clascoterone as a novel treatment for androgenetic alopecia
- Can male-pattern baldness be prevented?
- News in brief
- First reboxetine trial results reported
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches